Clinical trial
Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
NCT02798328 is registered in ClinicalTrials.gov with Haemonetics Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Direct Oral Anticoagulant Assay Detection & Classification Study for the TEG 6S System
- Lead sponsor
- Haemonetics Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2016
- Completion date
- September 30, 2017
- Enrollment
- 385 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.
doac eligible subjects